PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $76,875 | -53.4% | 25,000 | +100.0% | 0.04% | -56.7% |
| Q4 2022 | $165,000 | +123.0% | 12,500 | -50.0% | 0.09% | +246.2% |
| Q3 2022 | $74,000 | +60.9% | 25,000 | +100.0% | 0.03% | -10.3% |
| Q2 2022 | $46,000 | -40.3% | 12,500 | 0.0% | 0.03% | -31.0% |
| Q1 2022 | $77,000 | -69.0% | 12,500 | -24.9% | 0.04% | -68.9% |
| Q3 2021 | $248,000 | -40.7% | 16,655 | -50.0% | 0.14% | +7.1% |
| Q2 2021 | $418,000 | +175.0% | 33,310 | 0.0% | 0.13% | +152.0% |
| Q1 2021 | $152,000 | +322.2% | 33,310 | +100.0% | 0.05% | +108.3% |
| Q4 2020 | $36,000 | -53.8% | 16,655 | -50.0% | 0.02% | -25.0% |
| Q3 2020 | $78,000 | +136.4% | 33,310 | +100.0% | 0.03% | +10.3% |
| Q2 2020 | $33,000 | +175.0% | 16,655 | 0.0% | 0.03% | +123.1% |
| Q1 2020 | $12,000 | -72.7% | 16,655 | 0.0% | 0.01% | -65.8% |
| Q4 2019 | $44,000 | – | 16,655 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,499,149 | $18,814,000 | 3.39% |
| New Leaf Venture Partners, L.L.C. | 117,242 | $7,975,000 | 2.05% |
| Worth Venture Partners, LLC | 348,703 | $4,376,000 | 1.63% |
| INSPIRION WEALTH ADVISORS, LLC | 253,262 | $3,178,000 | 0.78% |
| EAM Global Investors LLC | 187,900 | $2,358,000 | 0.65% |
| EAM Investors, LLC | 279,613 | $3,509,000 | 0.54% |
| ACT CAPITAL MANAGEMENT, LLC | 45,000 | $565,000 | 0.29% |
| Andesa Financial Management Inc. | 33,310 | $418,000 | 0.13% |
| Monashee Investment Management LLC | 80,000 | $1,004,000 | 0.12% |
| Sofinnova Investments, Inc. | 142,635 | $1,790,000 | 0.10% |